» Articles » PMID: 19737610

Glucose and Corticosterone Changes in Developing and Adult Rats Following Exposure to (+/-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine

Overview
Specialties Neurology
Toxicology
Date 2009 Sep 10
PMID 19737610
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The use of the club drugs 3,4-methylenedioxymethamphetamine (MDMA) and 5-methoxy-n,n-diisopropyltryptamine (Foxy) is of growing concern, especially as many of the effects, particularly during development, are unknown. The effects of these drugs upon homeostasis may be important since both are known to stimulate the hypothalamic-pituitary-adrenal axis. The purpose of this experiment was to examine alterations in rats in corticosterone and glucose following an acute exposure to these drugs at different stages of development: preweaning, juvenile, and adulthood. Both MDMA and Foxy increased corticosterone levels significantly at all ages examined, while glucose was elevated at all stages except at the juvenile time point (postnatal day 28). For both measures, there were no differences between the sexes with either drug. The data indicate that an acute exposure to these drugs alters CORT and glucose levels, raising the possibility that these changes may have effects on behavioral and cognitive function, as we and others have previously demonstrated.

Citing Articles

Effects of the Phenethylamine 2-Cl-4,5-MDMA and the Synthetic Cathinone 3,4-MDPHP in Adolescent Rats: Focus on Sex Differences.

Pisanu A, Lo Russo G, Talani G, Bratzu J, Siddi C, Sanna F Biomedicines. 2022; 10(10).

PMID: 36289598 PMC: 9598216. DOI: 10.3390/biomedicines10102336.


Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods.

Lisdahl K, Sher K, Conway K, Gonzalez R, Feldstein Ewing S, Nixon S Dev Cogn Neurosci. 2018; 32:80-96.

PMID: 29559216 PMC: 6375310. DOI: 10.1016/j.dcn.2018.02.007.


Electroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats.

Graham D, Herring N, Schaefer T, Holland K, Vorhees C, Williams M Open Neuropsychopharmacol J. 2015; 5:1-8.

PMID: 25995775 PMC: 4435606. DOI: 10.2174/1876523801205010001.


The effects of ecstasy on liver function tests, blood glucose, and lipids profile of male rats.

Shahraki M, Irani M Int J High Risk Behav Addict. 2015; 3(4):e21076.

PMID: 25741481 PMC: 4331654. DOI: 10.5812/ijhrba.21076.


Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption.

Llorente-Berzal A, Puighermanal E, Burokas A, Ozaita A, Maldonado R, Marco E PLoS One. 2013; 8(11):e78386.

PMID: 24223797 PMC: 3817254. DOI: 10.1371/journal.pone.0078386.


References
1.
Wilson J, McGeorge F, Smolinske S, Meatherall R . A foxy intoxication. Forensic Sci Int. 2004; 148(1):31-6. DOI: 10.1016/j.forsciint.2004.04.017. View

2.
Skelton M, Able J, Grace C, Herring N, Schaefer T, Gudelsky G . (+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks. Neuropharmacology. 2008; 55(7):1121-30. PMC: 2703563. DOI: 10.1016/j.neuropharm.2008.07.006. View

3.
Alatrash G, Majhail N, Pile J . Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative. Mayo Clin Proc. 2006; 81(4):550-1. DOI: 10.4065/81.4.550. View

4.
Schaefer T, Ehrman L, Gudelsky G, Vorhees C, Williams M . Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat. J Neurochem. 2006; 98(5):1369-78. PMC: 2756091. DOI: 10.1111/j.1471-4159.2006.04034.x. View

5.
Ricaurte G, FORNO L, Wilson M, DELANNEY L, Irwin I, Molliver M . (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA. 1988; 260(1):51-5. View